BIOLOGICAL TISSUE ANALYSIS BY INVERSE SPECTROSCOPIC OPTICAL COHERENCE TOMOGRAPHY

    公开(公告)号:US20180017487A1

    公开(公告)日:2018-01-18

    申请号:US15590745

    申请日:2017-05-09

    Inventor: Vadim Backman Ji Yi

    CPC classification number: G01N21/4795 A61B5/0066

    Abstract: A method and system to measure and image the full optical scattering properties by inverse spectroscopic optical coherence tomography (ISOCT) is disclosed. Tissue is modeled as a medium with continuous refractive index (RI) fluctuation and such a fluctuation is described by the RI correlation functions. By measuring optical quantities of tissue (including the scattering power of the OCT spectrum, the reflection albedo α defined as the ratio of scattering coefficient μs, and the back-scattering coefficient μb), the RI correlation function can be inversely deduced and the full set of optical scattering properties can be obtained.

    MYOKINES FOR TREATING CELL PROLIFERATIVE AND METABOLIC DISEASES AND DISORDERS

    公开(公告)号:US20230340047A1

    公开(公告)日:2023-10-26

    申请号:US18151166

    申请日:2023-01-06

    CPC classification number: C07K14/475 A61K31/282 C07K14/4703 A61K38/00

    Abstract: Disclosed are compositions comprising myokines and their methods of preparation and use. The disclosed myokine compositions and methods may comprise myokines having a molecular weight of greater than about 10 kDa such as myostatin and metrnl. The disclosed myokine compositions and methods may be utilized for treating and/or preventing cell proliferative and metabolic diseases and disorders. In particular, the disclosed myokine compositions and methods may be utilized for treating and/or preventing cell proliferative and metabolic diseases and disorders, such as cancer, and metabolic diseases and disorders, such as diabetes, non-alcoholic fatty liver disease, and heart disease.

    Spectral contrast optical coherence tomography angiography

    公开(公告)号:US11525666B2

    公开(公告)日:2022-12-13

    申请号:US17055908

    申请日:2019-05-17

    Abstract: In an aspect, a method for imaging a target comprises steps of: performing optical coherence tomography (OCT) scanning on the target with one or more beams of source light, the one or more beams of source light comprising a plurality of wavelengths; wherein performing OCT scanning comprises: providing the source light to a reference optical path and to a sample optical path, wherein providing the source light to a sample optical path comprises illuminating the target with the source light; and recording interference data corresponding to an interaction of a light from the reference optical path and a light from the sample optical path; processing the interference data; and identifying blood or one or more blood-features in the target based on an optical attenuation of light in or associated with the sample optical path by the blood or the one or more blood-features.

Patent Agency Ranking